We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
SERUM LEVEL OF ISCHEMIA MODIFIED ALBUMIN IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION.
- Authors
Mahdi, Mahdi A.; Joad, Aumr T.; Ahmed, Salam S.; Khudhair, Khudhair A.
- Abstract
Acute myocardial chest pain is one of the most common diagnostic challenges in emergency medicine. Diagnosis principally focuses on identifying patients with acute coronary syndrome (ACS), who are at significant risk of adverse outcome and have the potential to benefit from inpatient care. The electrocardiography ECG provides a quick, cheap and simple way of identifying patients with ST segment changes, who are likely to benefit from admission and is therefore an essential tool for evaluating any patient with suspected ACS. However, some patients with chest pain and a normal or non-diagnostic ECG may also be at significant risk of adverse outcome. Biochemical cardiac markers, particularly troponins, can identify, which patients with a normal or non-diagnostic ECG are at higher risk. For selected patients, treadmill exercise testing can provide further prognostic information. Chest pain is the initial symptom of many life-threatening disease processes. Pain may arise from any structure located in the thoracic cavity. Cardiac causes of chest pain usually have anginal symptoms. Noncardiac causes have a variety of chest pain characteristics. Diseases that require immediate attention and intervention are myocardial infarction/unstable angina, dissecting aortic aneurysm, pericarditis, pulmonary embolism, pneumothorax, pneumonia, and acute chest syndrome (Fallon and Roques, 1997). Early identification of patients with acute myocardial infarction is of prime importance due to the associated very high mortality. A number of biochemical tests like CKMB and Troponin-T/I have been introduced for early detection of the coronary syndrome (ACS). Ischemia modified albumin (IMA) has been introduced as a marker of myocardial ischemia. IMA appears to be developing into a new and very potent marker of cardiac ischemia (Chawla et al, 2006).
- Subjects
ALBUMINS; BLOOD serum analysis; MYOCARDIAL infarction; CHEST pain; EMERGENCY medicine
- Publication
Biochemical & Cellular Archives, 2019, Vol 19, Issue 2, p4311
- ISSN
0972-5075
- Publication type
Article
- DOI
10.35124/bca.2019.19.2.4311